Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II Pivotal Clinical Trial of KN046 (KN046-205,ENREACH-Thymic) in the U.S.
2021-03-09 20:00
Nippon Express (Malaysia) Obtains GDP Certification for Domestic Transport Services
2021-03-09 15:00
Yangtze River Pharmaceutical (Group) Co., Ltd. Won the 2021 EFQM Global Award
2021-03-09 11:19
Winhealth Pharma and Merz Collaborate on Hepa-Merz® to benefit patients with liver disease in China
2021-03-09 10:00
CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein
2021-03-08 11:41
Adlai Nortye Announces Formation of its New Scientific Advisory Board
2021-03-08 09:00
Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA
2021-03-05 21:00
ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide
2021-03-05 20:00
Mayne Pharma launches another generic oral contraceptive
2021-03-05 05:34
Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States
2021-03-04 23:00
Yuyu Pharma Publishes History for 80th Anniversary
2021-03-03 22:00
I-Mab to Report Financial Results for the Full Year 2020 and Provide Corporate Update on March 29, 2021
2021-03-03 21:00
SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange
2021-03-03 16:43
CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project
2021-03-03 11:12
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody
2021-03-02 13:43
China Biologic Announces Shareholders' Approval of Merger Agreement
2021-03-01 21:00
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
2021-03-01 08:00
LISCure Biosciences Successfully Raises $21 million in Series B Funding
2021-02-26 22:00
Alterity to present at the 7th International Congress of Multiple System Atrophy
2021-02-26 20:45
Tigermed Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization
2021-02-26 16:36
1
108
109
110
111
112
165